| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10910958 | Lung Cancer | 2015 | 8 Pages |
Abstract
The serum-based proteomic test informed treatment selection for patients with advanced NSCLC who failed previous chemotherapy regimen(s), improving QALYs and saving costs.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
John Hornberger, Fred R. Hirsch, Qianyi Li, Ray D. Page,